Vaccination protects β2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection

Vaccine

Volumn 14, Issue 13, 1996, Pages 1223-1229

  Hildeman, David ^a   Salvato, Maria ^a   Whitton, J Lindsay ^b   Muller, Daniel ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

2 Microglobulin deficient mice; Lymphocytic choriomeningitis virus (LCMV); Persistent infection

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE DISRUPTION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MENINGITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; VACCINATION; VIRAL VACCINES;

EID: 0030250754     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00028-X     Document Type: Article

References (26)

1. 1 Bloom, B. and Rager-Zisman, B. Cell mediated immunity in viral infections. In: Viral Immunology and Immunopathology (Ed. Notkins, A.L.). Academic Press, New York, 1975, pp. 113-136
2. 2 Hirsch, V., Goldstein, S., Hayes, N. et al. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficency virus vaccine. J. Infect. Dis. 1994, 170, 51-59
3. 3 Legendre, A., Hawks, D., Sebring, R. et al. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure. J. Am. Vet. Med. Assoc. 1991, 199, 1456-1462
4. 4 Klavinskis, L., Tishon, A. and Oldstone, M.B.A. Efficiency and effectiveness of cloned virus specific cytotoxic T lymphocytes in vivo. J. Immunol. 1989, 143, 2013-2016
5. 5 Kagi, D., Lederman, B., Burki, K. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin deficient mice. Nature 1994, 369, 31-37
6. 2-microglobulin. Science 1990, 248, 1227-1230
7. 2-Microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990, 344, 742-746
8. 8 Doherty, P., Hou, S. and Southern, P.J. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J. Neuroimmunol. 1993, 46, 11-18
9. 2-microglobulin-deficient mice. Science 1992, 255, 1576-1578
10. 2-microglobulin gene. J. Virol. 1993, 67, 332-339
11. 11 Matloubian, M., Concepcion, R. and Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 1994, 68, 8056-8063
12. 12 Ahmed, R., Salmi, A., Butler, L., Chiller, J. and Oldstone, M.B.A. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 1984, 60, 521-540
13. 13 Oehen, S., Hengartner, H., Zinkernagel, R.M. Vaccination for disease. Science 1991, 251, 195-198
14. 2-microglobulin-deficient mice by CD4+ T cells. Int. Immunol. 1993, 5, 1193-1198
15. 15 Hany, M., Oehen, S., Schultz, M. et al. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 1989, 19, 417-424
16. 16 Klavinskis, L., Whitton, J.L. and Oldstone, M.B.A. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 1989, 63, 4311-4316
17. 17 Schultz, M., Aichele, P., Vollenweider, M. et al. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 1989, 19, 1657-1667
18. 18 Thomsen, A.R., Volkert, M. and Marker, O. The timing of the immune response in relation to virus growth determines the outcome of the LCM infection. Acta. Path. Microbiol. Scand. Sect. C 1979, 87, 47-54
19. 19 Whitton, J.L., Southern, P.J. and Oldstone, M.B.A. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 1988, 162, 321-327
20. 20 Mackett, M., Smith, G. and Moss, B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 1984, 49, 857-864
21. 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl Acad. Sci. USA 1992, 89, 6070-6074
22. 22 Mims, C.A. Intracerebral injections and the growth of viruses in the mouse brain. Br. J. Exp. Pathol. 1960, 41, 52-59
23. 23 Christensen, J., Marker, O. and Thomsen, A.R. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand. J. Immunol. 1994, 40, 373-382
24. 24 Raulet, D. MHC class I-deficient mice. Adv. Immunol. 1994, 55, 381-421
25. 25 Baldridge, J. and Buchmeier, M.J. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 1992, 66, 4252-4257
26. 26 Battegay, M., Kyburz, D., Hengartner, H., Zinkernagel, R.M. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur. J. Immunol. 1993, 23, 3236-3241